4D Molecular Therapeutics, Inc. (FDMT) closed the last trading session at $15.62, gaining 6.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $50.78 indicates a 225.1% upside potential. The mean estimate comprises nine short-term price targets with a standard deviation of $17.77. While the lowest estimate of $36 indicates a 130.5% increase from the current price level, the most op ...